Signal or noise? > AI Kidney Therapies - Trend Hunter >> Comment below! #strategy #competitiveintelligence #marketing #pharma #competitivemarketing #biotech #healthcare #pharmaceutical
AI Kidney Therapies - Trend Hunter
AI Kidney Therapies Trend Hunter
dlvr.it
January 22, 2026 at 3:30 AM
Signal or noise? > AI Kidney Therapies - Trend Hunter >> Comment below! #strategy #competitiveintelligence #marketing #pharma #competitivemarketing #biotech #healthcare #pharmaceutical
Increased use of multi-year funding reduces chances of research ideas being funded, postponing cures and therapies
via ActforNIH.org
NIH
via ActforNIH.org
NIH
January 22, 2026 at 3:23 AM
Increased use of multi-year funding reduces chances of research ideas being funded, postponing cures and therapies
via ActforNIH.org
NIH
via ActforNIH.org
NIH
🚨 Prospects of GLP-1 Therapies for Addiction and Mental Health Comorbidities—Quo Vadis?
jamanetwork.com/journals/jam...
@jamapsychiatry.com
jamanetwork.com/journals/jam...
@jamapsychiatry.com
GLP-1 Therapies for Addiction and Mental Health Comorbidities
This narrative review discusses the current landscape of glucagon-like peptide-1 therapies in the context of alcohol and other substance use disorders, mental health considerations, and gaps and oppor...
jamanetwork.com
January 22, 2026 at 3:08 AM
🚨 Prospects of GLP-1 Therapies for Addiction and Mental Health Comorbidities—Quo Vadis?
jamanetwork.com/journals/jam...
@jamapsychiatry.com
jamanetwork.com/journals/jam...
@jamapsychiatry.com
At @PsiAN, we advocate for therapies of depth, insight, and relationship—approaches that resolve underlying conflicts, not just manage symptoms.
January 22, 2026 at 2:59 AM
At @PsiAN, we advocate for therapies of depth, insight, and relationship—approaches that resolve underlying conflicts, not just manage symptoms.
Medicaid is doing a novel payment system for the new, promising and expensive sickle cell treatment. It may become a model for all gene therapies being developed. n.pr/4sMcFbq
Medicaid has a new way to pay for costly sickle cell treatment: Only if it works
Medicaid is doing a novel payment system for the new, promising and expensive sickle cell treatment. It may become a model for all gene therapies being developed.
n.pr
January 22, 2026 at 1:24 AM
Medicaid is doing a novel payment system for the new, promising and expensive sickle cell treatment. It may become a model for all gene therapies being developed. n.pr/4sMcFbq
The University of New South Wales (UNSW) has received $4.7 million from the Medical Research Future Fund to study long COVID.
Three Sydney-based projects will focus on:
• Developing new diagnostic tools
• Improving monitoring of long COVID
• Testing therapies to enhance care and support
Three Sydney-based projects will focus on:
• Developing new diagnostic tools
• Improving monitoring of long COVID
• Testing therapies to enhance care and support
UNSW Wins $4.7M Grant to Study Long COVID
The newly funded projects will support the development of tools and therapies to enhance support for people living with long COVID.
Three UNSW
www.miragenews.com
January 22, 2026 at 1:10 AM
The University of New South Wales (UNSW) has received $4.7 million from the Medical Research Future Fund to study long COVID.
Three Sydney-based projects will focus on:
• Developing new diagnostic tools
• Improving monitoring of long COVID
• Testing therapies to enhance care and support
Three Sydney-based projects will focus on:
• Developing new diagnostic tools
• Improving monitoring of long COVID
• Testing therapies to enhance care and support
New insight on mental health: https://bit.ly/4bueFPB
A new UK study suggests mindfulness especially acting with awareness may play a meaningful role in supporting well being for adults living with cystic fibrosis.
#CysticFibrosis #CysticFibrosisNewsToday #Mindfulness #WellBeing #Bionews #Hopeful
A new UK study suggests mindfulness especially acting with awareness may play a meaningful role in supporting well being for adults living with cystic fibrosis.
#CysticFibrosis #CysticFibrosisNewsToday #Mindfulness #WellBeing #Bionews #Hopeful
January 21, 2026 at 11:02 PM
New insight on mental health: https://bit.ly/4bueFPB
A new UK study suggests mindfulness especially acting with awareness may play a meaningful role in supporting well being for adults living with cystic fibrosis.
#CysticFibrosis #CysticFibrosisNewsToday #Mindfulness #WellBeing #Bionews #Hopeful
A new UK study suggests mindfulness especially acting with awareness may play a meaningful role in supporting well being for adults living with cystic fibrosis.
#CysticFibrosis #CysticFibrosisNewsToday #Mindfulness #WellBeing #Bionews #Hopeful
📢 Calling GPs, Practice Nurses, Mental Health Practitioners, TT Practitioners&Managers!
Join our Community of Practice Group to help improve NHS Talking Therapies for ethnic minority people with long-term conditions.
Quarterly online meetings | Reimbursed
📧 [email protected]
#MentalHealth #NHS
Join our Community of Practice Group to help improve NHS Talking Therapies for ethnic minority people with long-term conditions.
Quarterly online meetings | Reimbursed
📧 [email protected]
#MentalHealth #NHS
January 21, 2026 at 10:18 PM
📢 Calling GPs, Practice Nurses, Mental Health Practitioners, TT Practitioners&Managers!
Join our Community of Practice Group to help improve NHS Talking Therapies for ethnic minority people with long-term conditions.
Quarterly online meetings | Reimbursed
📧 [email protected]
#MentalHealth #NHS
Join our Community of Practice Group to help improve NHS Talking Therapies for ethnic minority people with long-term conditions.
Quarterly online meetings | Reimbursed
📧 [email protected]
#MentalHealth #NHS
this week’s teaching done. this class was a lot more receptive to energy/biofield therapies. slowly seeing them getting interested in different modalities. 💕
January 21, 2026 at 9:52 PM
this week’s teaching done. this class was a lot more receptive to energy/biofield therapies. slowly seeing them getting interested in different modalities. 💕
A modified CRISPR technique, epigenetic editing, avoids cutting DNA and instead targets chemical markers attached to genes to restore gene activity without altering underlying DNA. Researchers are testing the technique for sickle cell disease therapies and others.
This CRISPR breakthrough turns genes on without cutting DNA
A new CRISPR breakthrough shows scientists can turn genes back on without cutting DNA, by removing chemical tags that act like molecular anchors. The work confirms these tags actively silence genes, settling a long-running scientific debate. This gentler form of gene editing could offer a safer way to treat Sickle Cell disease by reactivating a fetal blood gene. Researchers say it opens the door to powerful therapies with fewer unintended side effects.
www.sciencedaily.com
January 21, 2026 at 9:37 PM
A modified CRISPR technique, epigenetic editing, avoids cutting DNA and instead targets chemical markers attached to genes to restore gene activity without altering underlying DNA. Researchers are testing the technique for sickle cell disease therapies and others.
How I'll be spending my birthday weekend with one kid down with Flu B, another kid with three therapies over the next 48 hours, and staring down a winter storm knowing that Cruz has fled the state again
a man in a blue shirt is reaching out his hands towards the camera .
ALT: a man in a blue shirt is reaching out his hands towards the camera .
media.tenor.com
January 21, 2026 at 8:33 PM
How I'll be spending my birthday weekend with one kid down with Flu B, another kid with three therapies over the next 48 hours, and staring down a winter storm knowing that Cruz has fled the state again
New lung cancer research insights 🎥
In this expert roundtable led by Dr. @jennifermarksmd, Dr. Elliot Brea shares ASCO 2025 updates on emerging cellular therapies, including CAR T-cell therapy, for NSCLC and SCLC—explained clearly and concisely.
Watch the full video: youtu.be/hLy10mitvG8
In this expert roundtable led by Dr. @jennifermarksmd, Dr. Elliot Brea shares ASCO 2025 updates on emerging cellular therapies, including CAR T-cell therapy, for NSCLC and SCLC—explained clearly and concisely.
Watch the full video: youtu.be/hLy10mitvG8
January 21, 2026 at 8:30 PM
New lung cancer research insights 🎥
In this expert roundtable led by Dr. @jennifermarksmd, Dr. Elliot Brea shares ASCO 2025 updates on emerging cellular therapies, including CAR T-cell therapy, for NSCLC and SCLC—explained clearly and concisely.
Watch the full video: youtu.be/hLy10mitvG8
In this expert roundtable led by Dr. @jennifermarksmd, Dr. Elliot Brea shares ASCO 2025 updates on emerging cellular therapies, including CAR T-cell therapy, for NSCLC and SCLC—explained clearly and concisely.
Watch the full video: youtu.be/hLy10mitvG8
This progress can lead to more precise diagnostics and targeted therapies, ultimately improving patient outcomes. Spatial gene expression maps could revolutionize how we approach treatment, making medicine more personalized and effective. #transcriptomics #biotech
January 21, 2026 at 8:12 PM
This progress can lead to more precise diagnostics and targeted therapies, ultimately improving patient outcomes. Spatial gene expression maps could revolutionize how we approach treatment, making medicine more personalized and effective. #transcriptomics #biotech
Get ready for an inspiring lineup at SSO’s Advanced Cancer Therapies 2026, taking place February 14-16, 2026, in Fort Lauderdale, FL. #ACT2026
Learn more and register now: https://ow.ly/NK6Z50Y0GG9
Learn more and register now: https://ow.ly/NK6Z50Y0GG9
January 21, 2026 at 8:01 PM
Get ready for an inspiring lineup at SSO’s Advanced Cancer Therapies 2026, taking place February 14-16, 2026, in Fort Lauderdale, FL. #ACT2026
Learn more and register now: https://ow.ly/NK6Z50Y0GG9
Learn more and register now: https://ow.ly/NK6Z50Y0GG9
Powering discovery.
Here's how the Sylvia Fedoruk Canadian Centre for Nuclear Innovation Inc. at #USask is advancing diagnostics, therapies, and research capacity through its cyclotron facility and strategic investments.
Read more:
news.usask.ca/articles/res...
Here's how the Sylvia Fedoruk Canadian Centre for Nuclear Innovation Inc. at #USask is advancing diagnostics, therapies, and research capacity through its cyclotron facility and strategic investments.
Read more:
news.usask.ca/articles/res...
Powering discovery. The Fedoruk Centre’s impact on health research - News
At the University of Saskatchewan (USask), the Sylvia Fedoruk Canadian Centre for Nuclear Innovation Inc. (Fedoruk Centre) is advancing diagnostics, therapies, and research capacity through its cyclot...
news.usask.ca
January 21, 2026 at 7:34 PM
Powering discovery.
Here's how the Sylvia Fedoruk Canadian Centre for Nuclear Innovation Inc. at #USask is advancing diagnostics, therapies, and research capacity through its cyclotron facility and strategic investments.
Read more:
news.usask.ca/articles/res...
Here's how the Sylvia Fedoruk Canadian Centre for Nuclear Innovation Inc. at #USask is advancing diagnostics, therapies, and research capacity through its cyclotron facility and strategic investments.
Read more:
news.usask.ca/articles/res...
Discover the novel approaches that are being investigated for the treatment of pancreatic ductal adenocarcinoma, from KRAS-targeted therapies to ADCs and vaccines.
👉 buff.ly/u8ScU3O
#PancreaticCancer
👉 buff.ly/u8ScU3O
#PancreaticCancer
January 21, 2026 at 7:25 PM
Discover the novel approaches that are being investigated for the treatment of pancreatic ductal adenocarcinoma, from KRAS-targeted therapies to ADCs and vaccines.
👉 buff.ly/u8ScU3O
#PancreaticCancer
👉 buff.ly/u8ScU3O
#PancreaticCancer
Discover the molecular biology of #glioblastoma and the involved signaling pathways and how this info is being used to develop next-gen therapies.
👉 buff.ly/fYlF1wT
#CancerTherapies #BrainTumor
👉 buff.ly/fYlF1wT
#CancerTherapies #BrainTumor
January 21, 2026 at 7:25 PM
Discover the molecular biology of #glioblastoma and the involved signaling pathways and how this info is being used to develop next-gen therapies.
👉 buff.ly/fYlF1wT
#CancerTherapies #BrainTumor
👉 buff.ly/fYlF1wT
#CancerTherapies #BrainTumor
Implications pour la prévention, la vaccination et le développement de thérapies précoces, afin d’éviter l’évolution vers une maladie chronique.
January 21, 2026 at 7:18 PM
Implications pour la prévention, la vaccination et le développement de thérapies précoces, afin d’éviter l’évolution vers une maladie chronique.
Our Neuromodulation business is dedicated to developing minimally invasive therapies and technologies that help patients manage debilitating chronic pain and movement disorders. Meet our new chief medical officer, Neuromodulation, Scott Kreiner, MD: news.bostonscientific.com/a-passion-fo...
A passion for helping people in pain: Meet Scott Kreiner, M.D.
He's hoping to change the lives of even more patients as Boston Scientific's new chief medical officer, Neuromodulation.
news.bostonscientific.com
January 21, 2026 at 7:04 PM
Our Neuromodulation business is dedicated to developing minimally invasive therapies and technologies that help patients manage debilitating chronic pain and movement disorders. Meet our new chief medical officer, Neuromodulation, Scott Kreiner, MD: news.bostonscientific.com/a-passion-fo...
Single-cell atlas of immune cells reveals complex inflammation patterns, paving the way for advanced disease classification and personalized therapies.
by Jiménez-Gracia L, Maspero D (...) Heyn H et 45 al. in Nat Med #MedSky
👉 get more here
📖 read the article:
by Jiménez-Gracia L, Maspero D (...) Heyn H et 45 al. in Nat Med #MedSky
👉 get more here
📖 read the article:
Interpretable inflammation landscape of circulating immune cells - Nature Medicine
Including data from 1,047 patients across 19 inflammatory diseases, a new atlas presents a comprehensive model of inflammation in circulating immune cells.
www.nature.com
January 21, 2026 at 6:59 PM
The sleep apnea market is about to change forever.
#$IXHL will be one of the first to offer alternative therapies to a condition that affects millions globally. It also enters a market that is a near monopoly.
Read: haphestus.com/ixhl-a-deep-...
#stocks #finance
#$IXHL will be one of the first to offer alternative therapies to a condition that affects millions globally. It also enters a market that is a near monopoly.
Read: haphestus.com/ixhl-a-deep-...
#stocks #finance
IXHL: A Deep Dive | Haphestus
Exploring IXHL, its sleep apnea drug IHL-42X, global market size and why this biotech offers a unique asymmetric investment setup.
haphestus.com
January 21, 2026 at 6:31 PM
The sleep apnea market is about to change forever.
#$IXHL will be one of the first to offer alternative therapies to a condition that affects millions globally. It also enters a market that is a near monopoly.
Read: haphestus.com/ixhl-a-deep-...
#stocks #finance
#$IXHL will be one of the first to offer alternative therapies to a condition that affects millions globally. It also enters a market that is a near monopoly.
Read: haphestus.com/ixhl-a-deep-...
#stocks #finance
Btw that antibody (pembro) also worked as a single agent, but another that failed out actually proved equally effective in combination therapies (nivo). Which is to say, the key might be finding the right extra switches to flip, in the other 75% of patients
January 21, 2026 at 6:20 PM
Btw that antibody (pembro) also worked as a single agent, but another that failed out actually proved equally effective in combination therapies (nivo). Which is to say, the key might be finding the right extra switches to flip, in the other 75% of patients
TLDR: as yet unknown components in the blood of ME/CFS & LC-19 patients actually causes damage to muscle tissue & mitochondria post exertion. This is a disease, it is not all in our heads, & resting does not make us worse & why graduated exercise therapies make us worse, not better. Post 1/5.
January 21, 2026 at 6:15 PM
TLDR: as yet unknown components in the blood of ME/CFS & LC-19 patients actually causes damage to muscle tissue & mitochondria post exertion. This is a disease, it is not all in our heads, & resting does not make us worse & why graduated exercise therapies make us worse, not better. Post 1/5.
🔬 What’s on the agenda at #GMFH2026?
From diet–microbiome interactions to microbiome-based therapies, the 2026 programme is packed with science you can take back to the clinic and the lab.
Explore the full agenda & join us in Porto next March!
https://bit.ly/3YOA5iO
From diet–microbiome interactions to microbiome-based therapies, the 2026 programme is packed with science you can take back to the clinic and the lab.
Explore the full agenda & join us in Porto next March!
https://bit.ly/3YOA5iO
January 21, 2026 at 6:03 PM
🔬 What’s on the agenda at #GMFH2026?
From diet–microbiome interactions to microbiome-based therapies, the 2026 programme is packed with science you can take back to the clinic and the lab.
Explore the full agenda & join us in Porto next March!
https://bit.ly/3YOA5iO
From diet–microbiome interactions to microbiome-based therapies, the 2026 programme is packed with science you can take back to the clinic and the lab.
Explore the full agenda & join us in Porto next March!
https://bit.ly/3YOA5iO
ten23 health & BD partner to enable supply chain readiness for the BD Libertas wearable injector. The full-service solution aims to speed development of large-volume, self-administered therapies.
#News #SupplyChain #WearableInjector #Biotech #Pharma #DrugDelivery #Partnership
#News #SupplyChain #WearableInjector #Biotech #Pharma #DrugDelivery #Partnership
Becton Dickinson and ten23 partner on wearable injector supply
Partnership will support the supply for Becton, Dickinson and Company's self-administered therapies with a ready-to-use, scalable platform.
druganddeviceworld.com
January 21, 2026 at 6:03 PM
ten23 health & BD partner to enable supply chain readiness for the BD Libertas wearable injector. The full-service solution aims to speed development of large-volume, self-administered therapies.
#News #SupplyChain #WearableInjector #Biotech #Pharma #DrugDelivery #Partnership
#News #SupplyChain #WearableInjector #Biotech #Pharma #DrugDelivery #Partnership